Japan’s Largest Dispensing Pharmacy Raises Sales And Profit Estimations
This article was originally published in PharmAsia News
Tokyo-based Ain Pharmaciez released March 5 results for the third fiscal quarter ending Jan. 31 and estimations for the fiscal year. The company reported increases in both sales and profits. For the whole year, Ain raised sales estimates by 8.5 percent to ¥115.3 billion, regular profits estimation increased by 9.4 percent to ¥4.72 billion and net profit increased by 30.5 percent to ¥2.1 billion. (Click here for more - Japanese language
You may also be interested in...
A Phase III trial testing the antibody-drug conjugate sacituzumab govitecan was stopped early for efficacy, boding well for the BLA pending at the US FDA.
Deal Snapshot: Six companies seek to collect convalescent plasma from COVID-19 survivors to quickly develop hyperimmune immunoglobulin therapy for serious complications of the virus.
Pharmaceutical companies struggling to keep up with coronavirus-related supply chain havoc asked to keep the US regulator informed as situation unfolds.